MGLD filing lists 11,670 Series B preferred, convertible to 233,400

Rhea-AI Filing Summary

Marygold Companies (MGLD) director reported an equity award on a Form 4. On November 7, 2025, the director acquired 4,854 shares of common stock at $1.03 as a restricted stock grant for board service, bringing beneficial ownership to 14,779 shares directly.

The grant vests beginning November 7, 2025, then monthly, with full vesting on October 7, 2026.

The filing also lists 11,670 shares of Series B Convertible Voting Preferred Stock held through a general partnership in which the reporting person is a 50% partner, convertible at any time into 233,400 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gonzalez Matt

(Last) (First) (Middle)

120 CALLE IGLESIA, UNIT B

(Street)

SAN CLEMENTE CA 92672

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marygold Companies, Inc. [ MGLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2025		A(1)		4,854	A	$1.03	14,779	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B, Convertible, Voting, Preferred Stock	(2)	09/08/2010		M		11,670(2)		(2)	(2)	Common Stock	233,400	$0.24	11,670(2)	D

Explanation of Responses:

1. Restricted shares granted on November 7, 2025, as compensation for services as a director for the period November 7, 2025 through November 6, 2026. [#] shares vested on November 7, 2025, and monthly thereafter and fully vesting on October 7, 2026.

2. The shares of Series B convertible, Voting, Preferred Stock ("Series B Preferred Stock") are owned by a general partnership of which the reporting person is a 50% partner. Each share of series B Preferred Stock is convertible at any time into 20 shares of common stock, $0.001 par value per share, of the issuer and without payment of additional consideration therefore.

	/s/ Matt Gonzalez	12/12/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Marygold (MGLD) disclose on this Form 4?

A director acquired 4,854 restricted shares on November 7, 2025 at $1.03, with total direct ownership now 14,779 shares.

How does the restricted stock vest for the MGLD director grant?

It began vesting on November 7, 2025, vests monthly thereafter, and fully vests on October 7, 2026.

What derivative securities are reported for MGLD?

The filing lists 11,670 shares of Series B Convertible Voting Preferred Stock, convertible into 233,400 common shares.

Who holds the Series B preferred reported for MGLD?

They are held by a general partnership in which the reporting person is a 50% partner.

What is the director’s common stock ownership after the reported transaction?

Direct beneficial ownership is 14,779 common shares following the grant.